🚀 ProPicks AI Hits +34.9% Return!Read Now

US STOCKS-Wall St dips after S&P notches record, Fed on deck

Published 10/30/2019, 04:24 AM
Updated 10/30/2019, 04:32 AM
US STOCKS-Wall St dips after S&P notches record, Fed on deck
US500
-
DJI
-
GOOGL
-
AAPL
-
IXIC
-
META
-
GOOG
-
SPXHC
-
SPLRCT
-
BYND
-

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Merck, Pfizer gain on upbeat earnings
* Alphabet falls after missing profit estimates
* Fed policy announcement due Wednesday
* Dow down 0.07%, S&P 500 down 0.08%, Nasdaq down 0.59%

(Updates to market close)
By Chuck Mikolajczak
NEW YORK, Oct 29 (Reuters) - The S&P 500 edged lower to snap
a four-session win streak on Tuesday and it retreated from a
record high as investors grappled with a flood of earnings and
the latest update on a potential trade deal between the U.S. and
China.
Hopes of a U.S.-China trade deal and expectations of another
interest rate cut by the Federal Reserve when it concludes its
two-day meeting on Wednesday have pushed stocks higher the past
several sessions, sending the S&P to its second straight record
intraday high.
But indexes pulled back after a U.S. administration official
told Reuters that Washington and Beijing are continuing to work
on an interim trade agreement, but it may not be completed in
time for the leaders of the two countries to sign in Chile next
month. "It is actually impressive that we have held these gains,
even if we are down slightly, it is a pretty impressive day
considering what is going on, that there hasn't been this hard
sell-off pressure," said JJ Kinahan, chief market strategist at
TD Ameritrade in Chicago.
"The encouraging thing is we are trading more on what you
should be trading on, that being earnings, and less on rumor and
innuendo, which is a nice change of pace and how the market
should work."
Tech .SPLRCT shares, which have been closely tied to trade
progress, lost ground after the report and were last down 0.92%.

Drugmakers Merck & Co Inc MRK.N and Pfizer Inc PFE.N
both gained after reporting upbeat third-quarter results to help
keep the Dow and S&P near the flat line. The healthcare sector
.SPXHC , which has been the second-worst performer among the 11
major S&P 500 sectors this year, rose 1.16% as the best
performer on the session as Merck gained 3.5% and Pfizer
advanced 2.5%. But shares of Google parent Alphabet Inc GOOGL.O , however,
lost 2.20% and weighed on the Nasdaq as its quarterly profit
missed estimates due to higher costs. Third-quarter earnings of S&P 500 companies have largely
been better than expected, with over 77% of the 236 firms to
report so far surpassing profit expectations, according to
Refinitiv data. Still, earnings are expected to decline by 1.9%
for the quarter.
Other big names reporting this week include tech and
internet heavyweights Apple Inc AAPL.O and Facebook Inc
FB.O , as well as oil majors Exxon Mobil Corp XOM.N and
Chevron Corp CVX.N .
The focus now shifts to the Fed meeting, where the central
bank is widely expected to deliver a quarter-percentage-point
interest rate cut for the third time this year.
The Dow Jones Industrial Average .DJI fell 20.04 points,
or 0.07%, to 27,070.68, the S&P 500 .SPX lost 2.54 points, or
0.08%, to 3,036.88 and the Nasdaq Composite .IXIC dropped
49.14 points, or 0.59%, to 8,276.85.
The S&P earlier in the session reached a high of 3,047.87,
its second straight intraday record.
General Motors Co GM.N gained 4.28% after its quarterly
net profit topped estimates, but the carmaker slashed its
earnings forecast for 2019 as the 40-day U.S. labor strike by
the United Auto Workers union brought virtually all of its North
American operations to a standstill. Beyond Meat Inc BYND.O tumbled 22.22% as the vegan burger
maker said it would need to offer more store discounts amid
rising competition. Shares of GrubHub Inc GRUB.N plunged 43.30% after the
online food delivery company warned of slowing growth as
customers opted to choose from a growing pool of rival
providers. Advancing issues outnumbered declining ones on the NYSE by a
1.08-to-1 ratio; on Nasdaq, a 1.03-to-1 ratio favored decliners.
The S&P 500 posted 40 new 52-week highs and no new lows; the
Nasdaq Composite recorded 95 new highs and 69 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.